8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Feb 1, 2023 · 3y ago · Accession 0001193125-23-021525
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acumen Pharmaceuticals, Inc.
- Ticker
- ABOS
- CIK
- 1576885
- Form type
- 8-K
- Filing date
- Feb 1, 2023
- Report date
- Feb 1, 2023
- Document
- d453609d8k.htm
- Size
- 13.6 MB